Daily Record Jan 25, 2016 By David Taylor
Multiple sclerosis patient Lucy Clarke is the first Scot to successfully have the radical stem cell treatment that’s being hailed as “miraculous” by experts. Medics are now hopeful that it could eradicate the degenerative neurological condition.
Lucy, from Inverness, had to raise £40,000 for treatment in Moscow as she didn’t qualify for a trial in the UK. But now she’s able to live a more pain-free life …
The Star Jan 19, 2016
Paralysed multiple sclerosis sufferers are walking again thanks to life-changing treatment in Sheffield.
A trial at the Royal Hallamshire Hospital has seen 20 patients receive bone marrow transplants using their own stem cells in a bid to ‘re-boot’ their immune systems, which has helped some people walk again.
The trial is also being run in the US, Sweden and Brazil.
Professor Basil Sharrack, from the Royal Hallamshire Hospital, said: “To …
LA Times Dec 3, 2015 Melissa Healy
An international conference on gene editing on Thursday left the door open to future use, in humans, of new techniques that alter an organism’s genetic architecture in ways that carry forward to future generations.
With questions of safety, need and ethics still unanswered, the U.S. National Academies of Sciences, Engineering and Medicine; the United Kingdom’s Royal Society; and the Chinese Academy of Science agreed that “it would be …
The Lancet Dec 15, 2015 Rebecca Cooney, Editor
Gene editing has swiftly become one of the most promising—and controversial—breakthroughs in genetic engineering.
With the entrance of CRISPR (clustered regularly interspaced short palindromic repeats), a technique using the Cas9 enzyme to cut strands of the genome at precisely targeted locations to insert, replace, or remove DNA, the manipulation of the genetic basis of human disease has once again come to the fore.
Much of the excitement …
MSUnites.com Nov 5, 2015
A new stem cell treatment has sent most of the MS patients who tried it into remission, halting the progression of the disease even several years afterwards.
In a recent clinical study at the COloroda Blood Cancer Institute 24 patients with relapsing remitting multiple sclerosis (RRMS) underwent a three month procedure destroying their immune systems and then had their immune systems restarted using stem cell therapy.
The clinical
Please keep the Nebraska Coalition for Ethical Research in mind especially as you shop online this holiday season. Amazon will donate 0.5% of the price of your eligible AmazonSmile purchases to Nebraska Coalition For Ethical Research whenever you shop on AmazonSmile. You may use this link for easier access http://smile.amazon.com/ch/35-2170959…
BioEdge Michael Cook Oct 31, 2015
It’s a sign of the times.
Ten years ago, the single most controversial issue in bioethics was probably the use of human embryonic stem cells. Since these can only be obtained by destroying human embryos, nearly every Western legislature had noisy and bitter debates. But all that died away soon after Japanese researcher Shinya Yamanaka developed induced pluripotent stem cells, which apparently have all the potential of embryonic cells …
Science Daily Hebrew University of Jersusalem Oct 14, 2015
Regenerative medicine is a new and expanding area that aims to replace lost or damaged cells, tissues or organs in the human body through cellular transplantation. Embryonic stem cells (ESCs) are pluripotent cells that are capable of long-term growth, self-renewal, and can give rise to every cell, tissue and organ in the fetus’s body. Thus, ESCs hold great promise for cell therapy as a source of …
Michael Cook BioEdge Oct 8, 2015
Warning that rapid advances in genetics make “designer babies” an increasing possibility, a United Nations panel today called for a moratorium on “editing” the human genome, pending wider public debate lest changes in DNA be transmitted to future generations or foster eugenics.
While acknowledging the therapeutic value of genetic interventions, the panel stressed that the process raises serious concerns, especially if the editing of the human genome should be …
Harvard Stem Cell Institute
The Harvard Stem Cell Institute is developing new therapies to repair kidney damage, reducing the need for dialysis and transplantation.
Diabetes is a corrosive illness. The imbalance of blood sugar causes small changes in the body that slowly lead to blurry vision, skin rashes, and damaged nerves. In serious cases, diabetes wears away the path of blood to the kidneys, causing eventual organ failure. In fact, half of all kidney failures …
